These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36198551)

  • 1. [Allogeneic hematopoietic cell transplantation for myelofibrosis: current status and future challenges].
    Takagi S
    Rinsho Ketsueki; 2022; 63(9):1252-1260. PubMed ID: 36198551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
    Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
    Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
    Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Ditschkowski M; Elmaagacli AH; Trenschel R; Gromke T; Steckel NK; Koldehoff M; Beelen DW
    Haematologica; 2012 Oct; 97(10):1574-81. PubMed ID: 22491742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation.
    Polverelli N; Farina M; D'Adda M; Damiani E; Grazioli L; Leoni A; Malagola M; Bernardi S; Russo D
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
    Chhabra S; Narra RK; Wu R; Szabo A; George G; Michaelis LC; D'Souza A; Dhakal B; Drobyski WR; Fenske TS; Jerkins JH; Pasquini MC; Rizzo RD; Saber W; Shah NN; Shaw BE; Hamadani M; Hari PN
    Biol Blood Marrow Transplant; 2020 May; 26(5):893-901. PubMed ID: 31982543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.
    Kekre N; Ho VT
    Am J Hematol; 2016 Jan; 91(1):123-30. PubMed ID: 26453238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019.
    McLornan DP; Yakoub-Agha I; Robin M; Chalandon Y; Harrison CN; Kroger N
    Haematologica; 2019 Apr; 104(4):659-668. PubMed ID: 30872371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.
    Savani M; Dulery R; Bazarbachi AH; Mohty R; Brissot E; Malard F; Bazarbachi A; Nagler A; Mohty M
    Br J Haematol; 2021 Nov; 195(4):495-506. PubMed ID: 33881169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
    Zang DY; Deeg HJ
    Curr Opin Hematol; 2009 Mar; 16(2):140-6. PubMed ID: 19468277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving allogeneic stem cell transplantation in myelofibrosis.
    Gagelmann N; Kröger N
    Int J Hematol; 2022 May; 115(5):619-625. PubMed ID: 35419771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib.
    Jaekel N; Behre G; Behning A; Wickenhauser C; Lange T; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2014 Feb; 49(2):179-84. PubMed ID: 24292520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation.
    Gagelmann N; Ditschkowski M; Bogdanov R; Bredin S; Robin M; Cassinat B; Shahswar R; Thol F; Heuser M; Socié G; Beelen D; Triviai I; Badbaran A; Kröger N
    Blood; 2019 May; 133(20):2233-2242. PubMed ID: 30760453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem-cell transplantation for myelofibrosis.
    Lavi N; Rowe JM; Zuckerman T
    Curr Opin Hematol; 2017 Nov; 24(6):475-480. PubMed ID: 28832353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
    Hernández-Boluda JC; Pereira A; Alvarez-Larran A; Martín AA; Benzaquen A; Aguirre L; Mora E; González P; Mora J; Dorado N; Sampol A; García-Gutiérrez V; López-Godino O; Fox ML; Reguera JL; Pérez-Encinas M; Pascual MJ; Xicoy B; Parody R; González-Pinedo L; Español I; Avendaño A; Correa JG; Vallejo C; Jurado M; García-Cadenas I; Osorio S; Durán MA; Sánchez-Guijo F; Cervantes F; Piñana JL
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2237-2244. PubMed ID: 32717433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for myelofibrosis in 2012.
    McLornan DP; Mead AJ; Jackson G; Harrison CN
    Br J Haematol; 2012 May; 157(4):413-25. PubMed ID: 22463701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years.
    Daghia G; Zabelina T; Zeck G; von Pein UM; Christopeit M; Wolschke C; Ayuk F; Kröger N
    Eur J Haematol; 2019 Oct; 103(4):370-378. PubMed ID: 31306511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosis].
    Fujishima M; Fujishima N; Kitadate A; Guo Y; Watanabe A; Ubukawa K; Nara M; Yoshioka T; Kameoka Y; Takahashi N
    Rinsho Ketsueki; 2017; 58(7):743-748. PubMed ID: 28781268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.